ABL Bio ranked among the top searched stocks on 11 days over the past month.

As of 10:30 AM on the 23rd, ABL Bio is trading at 35,850 KRW, down 2.45% from the previous day. This represents a 96.98% increase compared to May 27. ABL Bio is known as a specialized company developing bio-pharmaceuticals based on antibody therapeutics.

Today, foreign investors have sold a net 20,000 shares of ABL Bio, while institutions have bought a net 5,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 162,827 shares, while foreign investors and institutions have sold a net 116,479 shares and bought a net 38,593 shares, respectively.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm’s IPO... Discussing technology transfers with 15 big pharma companies."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing